Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of pinealon capsules in China. Welcome to wholesale bulk high quality pinealon capsules for sale here from our factory. Good service and reasonable price are available.
Pinealon capsules belong to a class of specialized brain-targeted peptide bioregulators, with the bioactive Glu-Asp-Arg tripeptide complex serving as their core functional ingredient. Optimized into solid oral capsule dosage form, the product improves gastrointestinal dissolution efficiency and facilitates steady ingredient absorption inside the digestive tract.
Clinically and daily, it adapts to multiple application scenarios: adjuvant recovery after craniocerebral trauma, functional rehabilitation following ischemic or hemorrhagic stroke, physical conditioning for people enduring long-term high-intensity mental workload, as well as routine brain function preservation for middle-aged and aging crowds prone to gradual cognitive recession. The product adopts refined minimalist formula design without redundant excipients or irrelevant auxiliary additives, featuring stable chemical properties under conventional storage conditions. Its mild safety profile permits continuous long-term oral administration, delivering targeted nutritional and regulatory support to sustain intact neurological health and stable cognitive performance.
Products Description
Pinealon COA
Memory and Attention Enhancement
Pinealon capsules improve memory retention and focused attention via three distinct core regulatory pathways. To start with, the active tripeptide ingredient markedly suppresses the overactivity of pro-apoptotic Caspase‑3 protein to block excessive neuronal apoptotic cascades. This suppression effectively cuts down massive neuronal loss triggered by cerebral oxidative stress, local tissue hypoxia and cumulative neurotoxin buildup within brain tissue, thereby safeguarding the complete histological structure and normal physiological function of critical cognitive-related brain areas including the hippocampus and prefrontal cortex.
Second, it modulates synaptic plasticity by regulating the expression of NMDA receptor subunit genes (Grin family), enhancing long-term potentiation (LTP), promoting synapse formation and signal transmission efficiency, and strengthening memory encoding, storage, and retrieval. Third, it improves neural energy metabolism by boosting mitochondrial ATP synthesis in neurons, alleviating brain fatigue, and enhancing sustained attention stability. Meanwhile, it promotes the synthesis and release of cognition-related neurotransmitters such as acetylcholine and glutamate, optimizing neural signal conduction and accelerating information processing.
Intervention for age-related cognitive decline:
Targeting age-associated memory loss, inattention, and brain fog, EDR peptide slows neurodegenerative progression. A 12-week clinical study in healthy individuals aged 45–65 showed that daily EDR peptide capsule intake improved delayed memory test scores by 28% and attention flexibility task performance by 50%.
Another study of 109 patients with cognitive impairment due to vascular encephalopathy or brain trauma confirmed that 20–30 days of combined EDR peptide therapy reduced subjective memory complaints by 2–3 times, with objective cognitive indicators (proofreading tests, digit span tests) significantly superior to the conventional treatment group.
Support for high-intensity mental work:
As a daily cognitive supplement instead of prescription drugs for neurodegenerative diseases, pinealon capsules provide targeted neuroprotection. Ideal for overworked professionals and students under heavy mental stress, it relieves fatigue, poor focus and slow thinking. Research verifies its core EDR tripeptide reduces fatigue markers, boosts complex task performance and alleviates overwork-induced cognitive decline.
Cognitive rehabilitation after neurological injury:
It is commonly applied during the rehabilitation period after craniocerebral trauma, cerebral stroke and brain injury resulting from neurosurgical operations. Its active peptide components help facilitate gradual restoration of impaired neural circuits in damaged brain tissue, effectively ameliorating common residual sequelae including memory deterioration and inattentiveness. With sustained supplementation, patients can achieve noticeable improvements in daily self-management capacity and long-term social adaptability.
Focused on physiological neural restoration as its core mechanism, the active EDR peptide exerts neither excitatory nor suppressive influences on central nervous excitability. It will not trigger drug dependence, drug tolerance or obvious adverse reactions after continuous administration, hence fitting long-term daily supplementation safely. Different from rapid-onset synthetic nootropics that deliver instant yet transient cognitive boosts, this ingredient features mild, sustained pharmacological efficacy.
Antidepressant and Anxiolytic Effects
01.Mechanism of Action: Multi-target Regulation for Relieving Emotional Disorders
Pinealon capsules modulates mood through three pathways: neurotransmitter balance, neuroendocrine regulation, and neuroinflammation inhibition. First, it balances central neurotransmitters by promoting serotonin and dopamine synthesis/release, enhancing the inhibitory effect of γ-aminobutyric acid (GABA), regulating glutamate excitability, correcting neurotransmitter imbalance in depression and anxiety, and alleviating low mood, tension, and irritability.
Second, it regulates the stress endocrine axis by lowering cortisol levels under chronic stress, attenuating hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis, and reducing stress-induced damage to emotional centers. Third, it inhibits neuroinflammation by reducing pro-inflammatory cytokines (e.g., IL-6, TNF-α) in the brain, relieving inflammation-mediated mood disorders, while enhancing endogenous melatonin synthesis to regulate circadian rhythms and indirectly improve sleep-mood linkage.
02.Clinical Application Scenarios
Intervention for mild to moderate depression and anxiety: Suitable for low mood, anhedonia, anxiety, insomnia, early awakening, and irritability caused by chronic stress, aging, or neurological decline. Clinical studies show that 20 days of EDR peptide intervention reduced anxiety scale scores by 35%, significantly improved depression-related emotional indicators, and synchronously enhanced emotional stability, sleep quality, and subjective well-being.
Relief of stress-related mood disorders: For emotional disturbances following post-traumatic stress, prolonged high pressure, or severe illness, it assists in regulating neural stress responses, relieving negative emotions such as tension, fear, and irritability, and enhancing psychological resilience.
Improvement of mood comorbidities in cognitive impairment: Middle-aged and elderly individuals with cognitive decline or brain injury often present with anxiety, depression, or apathy. EDR peptide improves both cognitive and emotional symptoms simultaneously, reducing barriers to cognitive rehabilitation.
03.Application Advantages and Safety
Compared with conventional antidepressants and anxiolytics, EDR peptide has no side effects such as dry mouth, dizziness, drowsiness, or sexual dysfunction, and no risk of drug dependence, making it ideal for long-term emotional maintenance and mild symptom intervention. It regulates mood through neural repair and neurotransmitter balance rather than simple neural inhibition, aligning with the physiological regulatory mechanisms of the central nervous system.
Synergistic Regulation of Cognition and Emotion
The core value of EDR peptide lies in its synergistic regulation of cognition and emotion, which reinforce each other. Improved memory and attention enhance emotional self-regulation, reducing irritability and helplessness caused by cognitive slowness. Stable mood and reduced stress lower neural stress damage, creating a favorable neural microenvironment for cognitive recovery.
This synergistic effect makes it particularly suitable for middle-aged and elderly populations, who commonly experience both cognitive decline and mood fluctuations. EDR peptide achieves dual improvements through a single intervention. Its comprehensive neuroprotective, antioxidant, and anti-inflammatory effects fundamentally delay central nervous system aging, supporting long-term brain health and emotional stability.
I. Core Raw Material Synthesis and Purity Control
The active ingredient of this capsules is the Glu-Asp-Arg tripeptide complex, manufactured via solid-phase peptide synthesis using L-glutamic acid, L-aspartic acid, and L-arginine as starting materials, through amino acid protection, coupling, cleavage, and purification. Synthesis is performed in ISO 9001 and cGMP-certified facilities at 20–22°C and 45%–50% humidity to prevent peptide degradation. Crude products are purified by high-performance liquid chromatography (HPLC) to remove impurities and truncated peptides, resulting in a final product purity of over 99%, verified by Janoshik independent laboratory, with a Certificate of Analysis (COA) provided for each batch.
Raw materials are solvent-free, with heavy metals (Pb, As, Hg) <1 ppm, complying with the United States Pharmacopeia (USP) and European Pharmacopoeia (EP) standards.
Stability, Packaging, Storage and Transportation
Finished products undergo accelerated stability testing (40°C/75% RH, 6 months) and long-term stability testing (25°C/60% RH, 24 months), showing a content decrease of <2% with no excessive degradation products. Packaging consists of pharmaceutical aluminum foil + PVC blisters, with desiccants in outer cartons. Storage conditions: 2–25°C, dry and light-protected, with a 5-year shelf life. Transportation is temperature-controlled to avoid high temperatures, humidity, and severe vibration, ensuring product stability.
II. Capsule Formulation and Excipient Selection
Each capsule contains 1 mg of EDR peptide tripeptide. Excipients include natural rice flour (filler) and hypromellose (HPMC) vegetable cellulose capsule shells, with no artificial additives, preservatives, gluten, dairy, or soy ingredients.
The formulation preserves peptide stability and avoids dissolution abnormalities caused by moisture absorption and cross-linking in gelatin shells.
All excipients are third-party tested, with microbial limits (bacteria, molds, yeasts) complying with cGMP requirements and no endotoxin contamination.
III. Manufacturing Process and Quality Control
Production is conducted in U.S. cGMP-certified and FDA-registered facilities. Process:
Raw material pretreatment: EDR peptide powder is sieved through a 200-mesh screen, blended with rice flour in proportion, and mixed in a 3D blender for 30 minutes to ensure content uniformity RSD <3%.
Capsule filling: Automated capsule filling machines deliver precise dosages, with weight variation controlled within ±3%; empty, damaged, or underfilled capsules are automatically rejected.
Polishing and printing: Soft brush polishing and thermal transfer printing for product name, dosage, and batch number.
Aluminum-plastic blister packaging: Forming at 120–150°C and heat sealing at 160–180°C for moisture and light protection.
Samples are taken every 15 minutes for testing of appearance, weight, content, and dissolution (≥85% in 30 minutes).
Monitoring During Administration and Adverse Reaction Management
Discontinue use and seek medical attention immediately if headache, insomnia, nausea, allergic reactions, or other discomforts occur.
Local injection reactions may be managed with cold compresses. Long-term users should undergo regular liver and kidney function tests and related parameter monitoring.
References
Regulations on the Management of Adverse Reactions of Peptide Drugs, Ministry of Health and Social Development of the Russian Federation.
Cellmano Biotech Limited. EDR peptide 98% Technical Data Sheet. 2024.NINGBO INNO PHARMCHEM CO.,LTD. Pharmaceutical-Grade EDR peptide Powder Specification. 2025.
Khavinson V, et al. EDR peptide increases cell viability by suppression of free radical oxidation and caspase-3 activation. Int J Clin Exp Med. 2012;5(2):179-85.
Pinealon (https://en.wikipedia.org/wiki/Pinealon)
FAQ
Q：Who is the ideal crowd to take Pinealon ?
A：Pinealon suits students, high-intensity working professionals, middle-aged and elderly people with declining brain function, as well as patients in rehabilitation after brain trauma or stroke. It relieves mental fatigue from long-term brain overload and helps improve residual cognitive sequelae during neural recovery.
Q：How does Pinealon differ from common quick-effect smart drugs?
A：Its core EDR tripeptide focuses on cellular neural repair instead of temporarily stimulating the central nerve. It causes no neural excitement, drug dependence or obvious side effects, with mild sustained efficacy to steadily optimize cognition via long-term cell regulation rather than transient instant improvement.
Q：Can Pinealon replace prescription drugs for neurodegenerative disorders?
A：It works as a daily cognitive health supplement instead of therapeutic prescription medicine. While it offers neuroprotective effects to slow cognitive deterioration, it cannot substitute formal clinical medication for the treatment of confirmed neurodegenerative illnesses.
Hot Tags: pinealon capsules, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale